Fig. 3From: Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancerPerformance of the multivariable radiomic models. The CT-based rad‐score for each patient in the primary cohort (A) and the validation cohort (C), respectively; The ROC curves of the CT-based radiomic models using different methods in the primary cohort (B) and the validation cohort (D), respectivelyBack to article page